Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies
Microbiology and Molecular Biology Reviews · 25.06.2026 · 90 (2)
DOI: 10.1128/mmbr.00090-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiology and Molecular Biology Reviews, erschienen am 25.06.2026. Verfasst von Dongsheng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Program of Infection and Inflammation, QIMR Berghofer, Herston, Queensland, Australia. Hauptthemen laut MEDLINE: Genome, Viral, Antiviral Agents, RNA Viruses, Defective Interfering Viruses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Viral defective interfering particles (DIPs) are produced during replication by many RNA viruses, acting as non-infectious particles containing defective viral genomes (DVGs). DVGs are most clearly defined and mechanistically understood in positive- and negative-strand RNA viruses, and this review focuses on these RNA viruses in which DVGs and DIPs are best characterized. DVGs function as molecular parasites that rely on co-infection with a standard virus to obtain essential viral proteins needed for their replication. This parasitic relationship interferes with wild-type virus replication, making DIPs attractive antiviral candidates because they resist viral escape through mutation. Beyond replication interference, DVGs have emerged as potent stimulators of innate immunity, capable of inhibiting diverse, unrelated viruses by triggering robust antiviral responses. These dual mechanisms, direct interference and immune activation, highlight the value of DIPs/DVGs as a versatile antiviral strategy. Advances in understanding DIP/DVG formation, immune modulation, and therapeutic engineering underscore their promise for broad-spectrum antiviral applications. This review explores recent breakthroughs and addresses the critical remaining challenges for DIPs/DVGs to progress from promising preclinical agents to effective clinical antivirals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program of Infection and Inflammation, QIMR Berghofer, Herston, Queensland, Australia.
- Global Virus Network (GVN) Center of Excellence, Australian Infectious Disease Research Centre, Brisbane, Queensland, Australia.
- Shanghai East Hospital, Tongji University, Shanghai, China.
- School of Medicine, Tongji University, Shanghai, China.
- Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: David Harrich
Förderung
- National Health and Medical Research Council
Zitieren
APA
Li, D., Lin, M. H., Hao, H., Zhou, P., Maniam, P., & Harrich, D. (2026). Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies. Microbiology and Molecular Biology Reviews, 90(2). https://doi.org/10.1128/mmbr.00090-25
Vancouver
Li D, Lin MH, Hao H, Zhou P, Maniam P, Harrich D. Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies. Microbiology and Molecular Biology Reviews. 2026;90(2). doi:10.1128/mmbr.00090-25
BibTeX
@article{Li2026,
author = {Li, Dongsheng and Lin, Min-Hsuan and Hao, Hongyun and Zhou, Ping and Maniam, Pramila and Harrich, David},
title = {Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies},
journal = {Microbiology and Molecular Biology Reviews},
year = {2026},
volume = {90},
number = {2},
doi = {10.1128/mmbr.00090-25}
}
EUVIMED